Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) — Stance & relative strength
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Healthcare · Pharmaceutical Products
$15.91▲+1.66%
Neutral · stance 47
TAK is not confirmed as a leader.
24 is not yet a leadership-grade RS read, Market Stance is 47
As of 2026-06-26, Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) has a 3-month relative strength percentile of 24 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 1.4%, relative volume 0.93×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Daily range, ATR, beta, and the math for a 1-ADR stop.
ADR% (20d)avg daily range
1.4%
ATR(14)14-day EMA
$0.28
ATR%ATR as % of close
1.75%
Beta vs SPY90d rolling
0.31
1-ADR stoprisk from close $15.91
$15.69−1.4%
COMPUTED · AS OF 2026-06-26
Pattern read
TAK is in a stage 3 topping pattern, week 2. Currently in a 86-day base; basing ADR 1.3% (broad 1.2%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: -1.9% / -0.7%.
Pure factual computation. Not a recommendation. See stage analysis.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
TAK ranks at the 44th percentile over 1 month, 24th percentile over 3 months, 53th percentile over 6 months, 49th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
TAK is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
TAK currently shows a 20-day average daily range (ADR%) of 1.4%, a 90-day beta versus the S&P 500 of 0.31. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
TickerStance computes TAK's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what TAK has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
No SEC EDGAR filings are linked to TAK in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.
§ Seasonality
10y · since 2022
Best monthNovon averageavg +5.12% · 75% win · n 4
Worst monthOcton averageavg -5.08% · 25% win · n 4
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
+3.8%
+3.4%
+1.1%
40%
20%
-0.9%
-0.7%
+2.9%
-3.0%
-5.1%
+5.1%
+3.0%
TAK monthly seasonality strip
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
1
TAK Jan
avg: 3.81%
median: 1.80%
win: 100%
σ: 4.50%
n: 4
2022-04-12 → 2026-05-29
TAK Feb
avg: 3.38%
median: 3.77%
win: 50%
σ: 5.72%
n: 4
2022-04-12 → 2026-05-29
TAK Mar
avg: 1.13%
median: 0.98%
win: 50%
σ: 5.29%
n: 4
2022-04-12 → 2026-05-29